Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
MPRIP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
MCEMP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MNT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MUC3A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SCARA5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BMP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GTF2H2C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EHBP1L1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FUT8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC01122 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
PCYT1B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LARP6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SF3B6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LILRA5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
LOC100505912 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MESP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NCLN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STK11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on